161 related articles for article (PubMed ID: 12794127)
1. IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils.
Bourke E; Cassetti A; Villa A; Fadlon E; Colotta F; Mantovani A
J Immunol; 2003 Jun; 170(12):5999-6005. PubMed ID: 12794127
[TBL] [Abstract][Full Text] [Related]
2. The membrane form of the type II IL-1 receptor accounts for inhibitory function.
Neumann D; Kollewe C; Martin MU; Boraschi D
J Immunol; 2000 Sep; 165(6):3350-7. PubMed ID: 10975853
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor.
Malinowsky D; Lundkvist J; Layé S; Bartfai T
FEBS Lett; 1998 Jun; 429(3):299-302. PubMed ID: 9662436
[TBL] [Abstract][Full Text] [Related]
4. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU
J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719
[TBL] [Abstract][Full Text] [Related]
5. Selectivity release of the type II decoy IL-1 receptor.
Orlando S; Polentarutti N; Mantovani A
Cytokine; 2000 Jul; 12(7):1001-6. PubMed ID: 10880245
[TBL] [Abstract][Full Text] [Related]
6. Role of IL-18 in the secretion of Il-1beta, sIL-1RII, and IL-1Ra by human neutrophils.
Jablonska E; Izycka A; Jablonska J; Wawrusiewicz N; Piecuch J
Immunol Invest; 2001 Aug; 30(3):221-9. PubMed ID: 11570642
[TBL] [Abstract][Full Text] [Related]
7. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding.
Cui X; Rouhani FN; Hawari F; Levine SJ
J Immunol; 2003 Dec; 171(12):6814-9. PubMed ID: 14662887
[TBL] [Abstract][Full Text] [Related]
8. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor.
Re F; Muzio M; De Rossi M; Polentarutti N; Giri JG; Mantovani A; Colotta F
J Exp Med; 1994 Feb; 179(2):739-43. PubMed ID: 8294881
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
[TBL] [Abstract][Full Text] [Related]
10. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.
Bossù P; Visconti U; Ruggiero P; Macchia G; Muda M; Bertini R; Bizzarri C; Colagrande A; Sabbatini V; Maurizi G
Am J Pathol; 1995 Dec; 147(6):1852-61. PubMed ID: 7495308
[TBL] [Abstract][Full Text] [Related]
11. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
12. IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes.
Pousset F; Cremona S; Dantzer R; Kelley KW; Parnet P
J Neurochem; 2001 Nov; 79(4):726-36. PubMed ID: 11723165
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen intermediates cause rapid release of the interleukin-1 decoy receptor from human myelomonocytic cells.
Sambo P; Fadlon EJ; Sironi M; Matteucci C; Introna M; Mantovani A; Colotta F
Blood; 1996 Mar; 87(5):1682-6. PubMed ID: 8634411
[TBL] [Abstract][Full Text] [Related]
14. Dansyl cadaverine regulates ligand induced endocytosis of interleukin-8 receptor in human polymorphonuclear neutrophils.
Ray E; Samanta AK
FEBS Lett; 1996 Jan; 378(3):235-9. PubMed ID: 8557108
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation.
Grewe M; Gyufko K; Budnik A; Ruzicka T; Olaizola-Horn S; Berneburg M; Krutmann J
J Invest Dermatol; 1996 Dec; 107(6):865-70. PubMed ID: 8941676
[TBL] [Abstract][Full Text] [Related]
16. Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation.
Attur MG; Dave MN; Leung MY; Cipolletta C; Meseck M; Woo SL; Amin AR
J Immunol; 2002 Feb; 168(4):2001-10. PubMed ID: 11823537
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA.
Liu C; Hart RP; Liu XJ; Clevenger W; Maki RA; De Souza EB
J Biol Chem; 1996 Aug; 271(34):20965-72. PubMed ID: 8702856
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated endocytosis of IL-8: a fluorescent microscopic evidence and implication of the process in ligand-induced biological response in human neutrophils.
Ray E; Samanta AK
Cytokine; 1997 Aug; 9(8):587-96. PubMed ID: 9245487
[TBL] [Abstract][Full Text] [Related]
20. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.
Bessis N; Guéry L; Mantovani A; Vecchi A; Sims JE; Fradelizi D; Boissier MC
Eur J Immunol; 2000 Mar; 30(3):867-75. PubMed ID: 10741403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
